BORSELLI, CRISTANA
BORSELLI, CRISTANA
A Real-Life Study on the Use of Tildrakizumab in Psoriatic Patients
2023-01-01 Campione, E; Lambiase, S; Gaeta Shumak, R; Galluzzo, M; Lanna, C; Costanza, G; Borselli, C; Artosi, F; Cosio, T; Tofani, L; Dattola, A; Di Daniele, F; Bianchi, L
Bimekizumab for the treatment of moderate to severe psoriasis: a real-world experience over 52 weeks from two Italian dermatology clinics
2025-12-01 Mortato, E; Artosi, F; Borselli, C; Compagnucci, I; Rivieccio, A; Lanna, C; Lambiase, S; Gaeta Shumak, R; Loconsole, F; Bianchi, L; Campione, E
Challenging case of tinea corporis and faciei in psoriatic patient treated with bimekizumab: The usefulness of mycological screening before biological therapies
2024-12-01 Cosio, T; Shumak, Rg; Borselli, C; Artosi, F; Gaziano, R; Campione, E
Prevalence of fungal colonization among patients with psoriasis in difficult-to-treat areas: impact of apremilast on mycotic burden and clinical outcomes
2024-01-01 Campione, E; Cosio, T; Pistoia, Es; Artosi, F; Shumack, Rg; Borselli, C; Rivieccio, A; Caputo, V; Favaro, M; Sorge, R; Pica, F; Bianchi, L; Gaziano, R
Why targeted therapeutics have provided benefit in psoriasis: looking at IL-17 biology
2022-01-01 Lanna, C; Lambiase, S; Gaeta Shumak, R; Borselli, C; Cosio, T; Dattola, A; Bianchi, L; Campione, E
| Data di pubblicazione | Titolo | Autore(i) | Tipo | File |
|---|---|---|---|---|
| 1-gen-2023 | A Real-Life Study on the Use of Tildrakizumab in Psoriatic Patients | Campione, E; Lambiase, S; Gaeta Shumak, R; Galluzzo, M; Lanna, C; Costanza, G; Borselli, C; Artosi, F; Cosio, T; Tofani, L; Dattola, A; Di Daniele, F; Bianchi, L | Articolo su rivista | |
| 1-dic-2025 | Bimekizumab for the treatment of moderate to severe psoriasis: a real-world experience over 52 weeks from two Italian dermatology clinics | Mortato, E; Artosi, F; Borselli, C; Compagnucci, I; Rivieccio, A; Lanna, C; Lambiase, S; Gaeta Shumak, R; Loconsole, F; Bianchi, L; Campione, E | Articolo su rivista | |
| 1-dic-2024 | Challenging case of tinea corporis and faciei in psoriatic patient treated with bimekizumab: The usefulness of mycological screening before biological therapies | Cosio, T; Shumak, Rg; Borselli, C; Artosi, F; Gaziano, R; Campione, E | Articolo su rivista | |
| 1-gen-2024 | Prevalence of fungal colonization among patients with psoriasis in difficult-to-treat areas: impact of apremilast on mycotic burden and clinical outcomes | Campione, E; Cosio, T; Pistoia, Es; Artosi, F; Shumack, Rg; Borselli, C; Rivieccio, A; Caputo, V; Favaro, M; Sorge, R; Pica, F; Bianchi, L; Gaziano, R | Articolo su rivista | |
| 1-gen-2022 | Why targeted therapeutics have provided benefit in psoriasis: looking at IL-17 biology | Lanna, C; Lambiase, S; Gaeta Shumak, R; Borselli, C; Cosio, T; Dattola, A; Bianchi, L; Campione, E | Articolo su rivista |